Etiracetam - Misplaced Pages

This is an old revision of this page, as edited by BogBot (talk | contribs) at 09:51, 28 August 2011 (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 09:51, 28 August 2011 by BogBot (talk | contribs) (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Etiracetam" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message)

Pharmaceutical compound

Etiracetam
Clinical data


Routes of administration	Oral
ATC code	none
Legal status
Legal status	Unscheduled (US)
Identifiers
IUPAC name (RS)-2-(2-oxopyrrolidin-1-yl)butanamide
CAS Number	33996-58-6
PubChem CID	59708
ChemSpider	53863
UNII	230447L0GL
CompTox Dashboard (EPA)	DTXSID5046510
ECHA InfoCard	100.111.445
Chemical and physical data
Formula	C₈H₁₄N₂O₂
Molar mass	170.209 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES CCC(C(=O)N)N1CCCC1=O
InChI InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12) Key:HPHUVLMMVZITSG-UHFFFAOYSA-N
(verify)

Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active enantiomeric form is levetiracetam.

See also